Kairos Pharma Ltd (AMEX:KAPA) shares, rose in value, with the stock price up by 8.53% to the previous day’s close as strong demand from buyers drove the stock to $0.66.
Actively observing the price movement in the recent trading, the stock is buoying the session at $0.61. Referring to stock’s 52-week performance, its high was $4.00, and the low was $0.40. On the whole, KAPA has fluctuated by 12.58% over the past month.
With the market capitalization of Kairos Pharma Ltd currently standing at about $11.19 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
The stock’s technical analysis shows that the price of KAPA currently trading nearly 19.17% and -5.72% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.28, while the 7-day volatility ratio is showing 7.39% which for the 30-day chart, stands at 10.75%. Furthermore, Kairos Pharma Ltd (KAPA)’s average true range (ATR) is 0.08.
Data on historical trading for Kairos Pharma Ltd (AMEX:KAPA) indicates that the trading volumes over the past 3 months, they’ve averaged 728.67K. According to company’s latest data on outstanding shares, there are 15.83 million shares outstanding.
Nearly 57.73% of Kairos Pharma Ltd’s shares belong to company insiders and institutional investors own 9.36% of the company’s shares. The stock has fallen by -56.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the KAPA stock heading into the next quarter.
